(ULTA) Ulta Beauty - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90384S3031

Stock: Cosmetics, Skincare, Fragrance, Haircare, Beauty Tools

Total Rating 73

Risk 45

Buy Signal 0.72

Specialty Retail » Other Specialty Retail
Age: 18.3y

Market Cap: 28,297m
Avg Trading Vol: 357M USD

ATR: 2.49%
Peers RS (IBD): 76.19

EPS (Earnings per Share)

EPS CAGR: -1.36%
EPS Trend: 5.6%

Last SUE: 1.13
Qual. Beats: 5

Revenue

Rev. CAGR: 1.23%
Rev. Trend: 40.5%

Last SUE: 3.05
Qual. Beats: 3

Risk 5d forecast
Volatility	34.3%
Relative Tail Risk	-15.3%

Reward TTM
Sharpe Ratio	1.51
Alpha	54.02

Character TTM
Beta	0.865
Beta Downside	0.610

Drawdowns 3y
Max DD	44.56%
CAGR/Max DD	0.23

Description: ULTA Ulta Beauty December 17, 2025

Ulta Beauty, Inc. (NASDAQ:ULTA) is a U.S.-based specialty beauty retailer operating stores, shop-in-shops, an e-commerce platform, and mobile apps across the United States, Mexico, and Kuwait. The company sells a mix of branded and private-label cosmetics, fragrance, hair-care, skin-care, bath-and-body, professional hair products, and salon styling tools, while also offering in-store services such as hair, makeup, brow, and skin treatments.

Key recent metrics: for FY 2024, Ulta reported comparable-store sales growth of 8.2% and a 12-month trailing gross margin of ~38%, reflecting strong demand for premium beauty products and services. The “beauty-as-a-service” model-driven by higher-margin salon offerings-contributes roughly 30% of total revenue, cushioning the business against pure product-price pressure. Macro-level, consumer discretionary spending remains sensitive to disposable-income trends and inflation, but the sector benefits from a long-term shift toward “self-care” and “look-good-feel-good” spending patterns.

For a deeper, data-driven view of Ulta’s valuation and risk profile, you might explore the analyst tools on ValueRay to see how these drivers stack up against peers.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income: 1.19b TTM > 0 and > 6% of Revenue
FCF/TA: 0.15 > 0.02 and ΔFCF/TA -1.87 > 1.0
NWC/Revenue: 6.95% < 20% (prev 10.02%; Δ -3.07% < -1%)
CFO/TA 0.19 > 3% & CFO 1.36b > Net Income 1.19b
Net Debt (2.37b) to EBITDA (1.87b): 1.27 < 3
Current Ratio: 1.33 > 1.5 & < 3
Outstanding Shares: last quarter (44.9m) vs 12m ago -4.67% < -2%
Gross Margin: 39.19% > 18% (prev 0.39%; Δ 3880 % > 0.5%)
Asset Turnover: 184.8% > 50% (prev 190.7%; Δ -5.94% > 0%)
Interest Coverage Ratio: 383.1 > 6 (EBITDA TTM 1.87b / Interest Expense TTM 4.12m)

Altman Z'' 3.53

A: 0.12 (Total Current Assets 3.37b - Total Current Liabilities 2.54b) / Total Assets 7.01b
B: 0.22 (Retained Earnings 1.58b / Total Assets 7.01b)
C: 0.24 (EBIT TTM 1.58b / Avg Total Assets 6.49b)
D: 0.36 (Book Value of Equity 1.58b / Total Liabilities 4.38b)
Altman-Z'' Score: 3.53 = A

Beneish M -1.21

DSRI: 1.05 (Receivables 237.4m/213.6m, Revenue 11.98b/11.36b)
GMI: 0.99 (GM 39.19% / 38.67%)
AQI: 3.99 (AQ_t 0.08 / AQ_t-1 0.02)
SGI: 1.05 (Revenue 11.98b / 11.36b)
TATA: -0.02 (NI 1.19b - CFO 1.36b) / TA 7.01b)
Beneish M-Score: -1.21 (Cap -4..+1) = D

What is the price of ULTA shares?

As of February 07, 2026, the stock is trading at USD 690.37 with a total of 467,837 shares traded.
Over the past week, the price has changed by +6.64%, over one month by +6.20%, over three months by +35.41% and over the past year by +71.90%.

Is ULTA a buy, sell or hold?

Ulta Beauty has received a consensus analysts rating of 3.68. Therefor, it is recommend to hold ULTA.

StrongBuy: 9
Buy: 4
Hold: 13
Sell: 1
StrongSell: 1

What are the forecasts/targets for the ULTA price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	674.6	-2.3%
Analysts Target Price	674.6	-2.3%
ValueRay Target Price	813.5	17.8%

ULTA Fundamental Data Overview January 31, 2026

P/E Trailing = 24.2172
P/E Forward = 22.4719
P/S = 2.3617
P/B = 10.633
P/EG = 2.6713
Revenue TTM = 11.98b USD
EBIT TTM = 1.58b USD
EBITDA TTM = 1.87b USD
Long Term Debt = 2.02b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 842.4m USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.37b USD (from netDebt column, last quarter)
Enterprise Value = 30.67b USD (28.30b + Debt 2.57b - CCE 204.9m)
Interest Coverage Ratio = 383.1 (Ebit TTM 1.58b / Interest Expense TTM 4.12m)
EV/FCF = 29.47x (Enterprise Value 30.67b / FCF TTM 1.04b)
FCF Yield = 3.39% (FCF TTM 1.04b / Enterprise Value 30.67b)
FCF Margin = 8.69% (FCF TTM 1.04b / Revenue TTM 11.98b)
Net Margin = 9.93% (Net Income TTM 1.19b / Revenue TTM 11.98b)
Gross Margin = 39.19% ((Revenue TTM 11.98b - Cost of Revenue TTM 7.29b) / Revenue TTM)
Gross Margin QoQ = 40.44% (prev 39.15%)
Tobins Q-Ratio = 4.37 (Enterprise Value 30.67b / Total Assets 7.01b)
Interest Expense / Debt = 0.16% (Interest Expense 4.12m / Debt 2.57b)
Taxrate = 24.13% (73.4m / 304.3m)
NOPAT = 1.20b (EBIT 1.58b * (1 - 24.13%))
Current Ratio = 1.33 (Total Current Assets 3.37b / Total Current Liabilities 2.54b)
Debt / Equity = 0.98 (Debt 2.57b / totalStockholderEquity, last quarter 2.63b)
Debt / EBITDA = 1.27 (Net Debt 2.37b / EBITDA 1.87b)
Debt / FCF = 2.28 (Net Debt 2.37b / FCF TTM 1.04b)
Total Stockholder Equity = 2.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.35% (Net Income 1.19b / Total Assets 7.01b)
RoE = 46.87% (Net Income TTM 1.19b / Total Stockholder Equity 2.54b)
RoCE = 34.62% (EBIT 1.58b / Capital Employed (Equity 2.54b + L.T.Debt 2.02b))
RoIC = 44.43% (NOPAT 1.20b / Invested Capital 2.70b)
WACC = 8.35% (E(28.30b)/V(30.87b) * Re(9.10%) + D(2.57b)/V(30.87b) * Rd(0.16%) * (1-Tc(0.24)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.50%
[DCF Debug] Terminal Value 77.06% ; FCFF base≈1.02b ; Y1≈1.04b ; Y5≈1.14b
Fair Price DCF = 366.7 (EV 18.64b - Net Debt 2.37b = Equity 16.27b / Shares 44.4m; r=8.35% [WACC]; 5y FCF grow 1.36% → 2.90% )
EPS Correlation: 5.57 | EPS CAGR: -1.36% | SUE: 1.13 | # QB: 5
Revenue Correlation: 40.51 | Revenue CAGR: 1.23% | SUE: 3.05 | # QB: 3
EPS next Quarter (2026-04-30): EPS=7.24 | Chg30d=-0.013 | Revisions Net=-2 | Analysts=16
EPS next Year (2027-01-31): EPS=28.49 | Chg30d=+0.230 | Revisions Net=+5 | Growth EPS=+11.4% | Growth Revenue=+6.5%

Additional Sources for ULTA Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle